Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.unjhaformulations.com | |
Market Cap | 8.47 Cr. | |
Enterprise Value(EV) | 8.47 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.52 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 36.50 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 6.49 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 2.91 | Calculated using Price: 18.90 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.45 Cr. | 4,480,500 Shares |
FaceValue | 10 | |
About Unjha Formulations Ltd. | ||
Unjha Formulations (U-For), incorporated in 1987, is the sister concern of Urvesh Psyllium Industries Limited. U-For is the pharmaceuticals manufacturing unit, which is going to various category of formulation like tablet, capsule, oral liquids, injectables (SVP) and powder section to manufacture ayurvedic as well as allopathy products. |
1 Day |
|
+5.00% |
1 Week |
|
-1.15% |
1 Month |
|
-10.43% |
3 Month |
|
+21.94% |
6 Month |
|
-5.41% |
1 Year |
|
+54.29% |
2 Year |
|
+93.25% |
5 Year |
|
+127.71% |
10 Year |
|
+759.09% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 244.18 | 89.75 | 52.48 | 31.18 | 24.22 | 18.57 | 5.55 | 12.35 | 12.22 | |
Return on Capital Employed (%) | 68.66 | 73.7 | 67.61 | 32.15 | 25.41 | 25.57 | 26.8 | 21.13 | 16.76 | |
Return on Assets (%) | 4.92 | 8.26 | 8.82 | 6.79 | 7.89 | 8.37 | 2.86 | 7.23 | 8.23 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | |
Non Curr. Liab. | 0 | ||||||||||
Curr. Liab. | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 2 | |
Minority Int. | |||||||||||
Equity & Liab. | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 5 | |
Non Curr. Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Curr. Assets | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 4 | |
Misc. Exp. not W/O | 0 | 0 | 0 | 0 | |||||||
Total Assets | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 5 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 9 | 10 | 12 | 11 | 11 | 11 | 10 | 14 | 13 | 17 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 9 | 10 | 12 | 11 | 12 | 11 | 10 | 14 | 13 | 17 | |
Total Expenditure | -9 | -10 | -12 | -11 | -11 | -10 | -10 | -14 | -13 | -17 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | |||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | -1 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | |
Cash & Cash Eqvt | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
Fri, 29 Mar 2024
Board Meeting Outcome for OUTCOME OF BOARD MEETING Intimation of Board Meeting as per SEBI (LODR) Regu 2015 |
Tue, 26 Mar 2024
Board Meeting Intimation for Board Meeting - Date: 29.03.2024 UNJHA FORMULATIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2024 inter alia to consider and approve Ref: Clause 29(1)(a) of SEBI(Listing Obligation and Disclosure Requirement) Regulations 2015. |
Tue, 30 Jan 2024
Publish Un- Audited Financial Results For The Third Quarter & Nine Month Ended As On 31.12.2023 REGU. 33(3) OF SEBI(LODR) 2015 |
Thu, 28 Mar 2024 |
High Delivery Percentage |
Opening at Low |
Opening at Low for 3 days |
Closing Above Previous High |
Opening at Low for 2 Days |